Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Pavankumar Wankhade*, Shraddha Suryawanshi"'
Sitagliptin is an orally administered, potent, and highly selective inhibitor of dipeptidyl peptidase-4 (DPP-4) and was the first agent of its class to be approved for use in the management of adults with type 2 diabetes. Numerous randomized placebo-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d11fb6eca80ec20fa8edf307d1e6218
